CDKN2B-AS1 rs1333042: Vascular Health and Fitness
The rs1333042 variant is a common single-nucleotide polymorphism located within the 9p21.3 genomic locus overlapping the CDKN2B-AS1 gene. In human population genetics, this variant is primarily studied for its associations with vascular compliance, cardiorespiratory fitness reserve, and exercise blood pressure dynamics. Because it resides in a well-known cardiovascular risk hotspot, its statistical connections reflect broad vascular and metabolic traits rather than direct deterministic outcomes.
What each genotype means
Typical vascular response to exercise
You carry two copies of the A allele at this 9p21.3 non-coding locus. In observational fitness and exercise genomics studies, this genotype is generally associated with typical cardiorespiratory reserve and standard vascular blood pressure adaptation during physical exertion. However, evidence connecting this locus specifically to fitness parameters remains limited, and individual cardiovascular adaptation is predominantly shaped by exercise habits and general lifestyle.
Carried by roughly 25% to 30% of individuals globally, though frequencies vary modestly across different ancestral populations.
Intermediate cardiorespiratory reserve profile
You carry one copy of the C allele and one copy of the A allele at rs1333042. Some cardiovascular fitness studies report that carrying a single C allele is associated with intermediate vascular compliance and slight differences in exercise blood pressure response. Because scientific evidence linking this variant directly to exercise performance is limited and correlation does not imply clinical impairment, regular physical training remains the primary determinant of fitness.
Carried by approximately 45% to 50% of people across most global populations, representing the most common genotype.
Altered vascular exercise response profile
You have two copies of the C allele at this 9p21.3 intergenic locus. Limited research suggests this genotype is statistically correlated with differences in vascular compliance, altered peak exercise blood pressure, and modest variations in cardiorespiratory fitness reserve. These findings reflect small population-level statistical associations rather than direct individual outcomes, meaning consistent aerobic training and overall cardiovascular habits remain far more influential.
Carried by approximately 20% to 25% of individuals worldwide, with higher frequencies observed in European and East Asian cohorts than in African ancestry groups.
Genomic Location and the 9p21.3 Hotspot
The single-nucleotide polymorphism rs1333042 represents an A-to-G transition located on chromosome 9 at the cytogenetic band 9p21.3. This region is recognized across international genetics consortia as one of the most prominent genomic loci linked to cardiovascular physiology and arterial remodeling. Unlike coding variants that directly alter protein sequences, rs1333042 is an intergenic or non-coding regulatory variant mapped within the CDKN2B-AS1 transcriptional domain. It frequently segregates in strong linkage disequilibrium with other well-characterized 9p21 variants, meaning that an individual carrying alleles at this site often co-inherits a broader contiguous haplotype. Because of its location in a gene-dense regulatory nexus, genomic researchers evaluate rs1333042 as an important marker tag for regional chromatin behavior and transcriptional control, rather than as an isolated functional switch operating entirely in isolation.
Function of the CDKN2B-AS1 Locus
CDKN2B-AS1, also known as ANRIL (Antisense Non-coding RNA in the INK4 Locus), is a long non-coding RNA (lncRNA) gene that coordinates epigenetic regulation in human tissues. Rather than translating into a structural or enzymatic protein, CDKN2B-AS1 transcripts act as molecular scaffolds and recruiters for chromatin-modifying complexes. Through these pathways, it regulates the expression of neighboring tumor suppressor and cell-cycle genes, specifically CDKN2A and CDKN2B. These neighboring genes encode key cyclin-dependent kinase inhibitors that control cellular senescence, vascular smooth muscle cell proliferation, and endothelial tissue stability. Alterations in CDKN2B-AS1 transcript levels or splicing can influence how blood vessel walls remodel over time in response to physical stress, shear forces, and systemic inflammation, thereby linking this locus biologically to vascular tone and structural vessel integrity.
Evidence for Fitness and Vascular Associations
In genetic epidemiology, rs1333042 has been studied in cohorts evaluating exercise capacity, exercise-induced blood pressure response, and cardiorespiratory fitness reserve. Researchers hypothesize that subtle changes in vascular compliance and arterial elasticity can affect how efficiently blood vessels dilate during physical exertion. However, the overall strength of evidence for rs1333042 specifically dictating fitness performance remains limited and preliminary. While its association with broad coronary artery disease phenotypes and vascular calcification is extensively cataloged across large-scale genome-wide association studies, its direct micro-effects on aerobic athletic capacity or functional fitness reserve show modest effect sizes with notable variation across cohorts. As a result, having a particular allele does not determine high or low physical stamina, but rather reflects minor baseline statistical variance in vascular hemodynamic response.
Interpreting Genetic Data Responsibly
Personal genetic information regarding rs1333042 should be understood as an educational indicator of inherited background rather than a clinical diagnostic test. A genotype at this single non-coding position cannot diagnose heart disease, predict an inevitable heart attack, or define an individual's maximal athletic potential. Cardiorespiratory fitness, blood pressure regulation, and lifelong vascular integrity are complex multifactorial traits driven predominantly by regular physical activity, nutrition, sleep quality, and smoking avoidance. Knowing your rs1333042 genotype does not necessitate a specialized workout routine or medical therapy. For individuals monitoring cardiovascular performance, blood pressure targets, or cardiovascular risk factors, clinical health guidelines and direct consultation with a qualified medical provider remain the authoritative framework.
How common is this variant?
The rs1333042 variant is balanced across global populations, with a minor allele frequency of approximately 0.47 in global reference datasets. Both the A and G alleles occur commonly across diverse ancestral backgrounds, making heterozygous and homozygous genotypes frequent worldwide.
Frequently asked questions
Can rs1333042 predict my athletic endurance or VO2 max?
No. While rs1333042 is linked in research to subtle vascular compliance differences and cardiorespiratory fitness reserve, its individual statistical impact is very small. Actual aerobic capacity and VO2 max are influenced by hundreds of genetic variants alongside structured physical training, diet, and lifestyle.
Does having the rs1333042 GG genotype mean I will develop heart disease?
No, carrying the GG genotype does not mean you will develop heart disease. The G allele is linked to modest statistical risk differences in population studies, but it is not a diagnostic mutation. Established lifestyle factors and clinical markers like blood pressure and lipid levels remain far more consequential.
What is the CDKN2B-AS1 gene?
CDKN2B-AS1 produces a long non-coding RNA that acts as an epigenetic regulator of cell growth, senescence, and tissue remodeling. It does not produce a protein but regulates adjacent genes on chromosome 9 that govern vascular cell proliferation.
Should I modify my exercise regimen based on my rs1333042 results?
There is no clinical or scientific evidence supporting specific workout plans tailored to rs1333042 alleles. Regular cardiovascular exercise benefits vascular compliance and heart health regardless of which genotype you carry. Always consult a physician or exercise professional before making major changes to your fitness routine.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1333042?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2B-AS1
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.
A non-coding variant in the CDKN2B-AS1 locus associated with human longevity and survival beyond 90 years of age.
Non-coding RNA locus SNP associated with endometriosis development through altered regulation of cell cycle progression and local tissue remodeling.
This variant is a well-established risk locus for coronary artery disease and related cardiovascular conditions.
Located in the non-coding CDKN2B-AS1 locus, this variant confers significant risk for normal-tension and primary open-angle glaucoma.
Chromosome 9p21 non-coding regulatory variant conferring increased predisposition to coronary artery disease, myocardial infarction, and intracranial aneurysm.